{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:37:01Z","timestamp":1787697421968,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Self-financing project of Guangxi Health Commission","award":["Z-B20221294"],"award-info":[{"award-number":["Z-B20221294"]}]},{"name":"Guangxi Natural Science Foundation","award":["2020GXNSFDA297014"],"award-info":[{"award-number":["2020GXNSFDA297014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the risk factors for dilated cardiomyopathy (DCM) and construct a risk model for predicting HF in patients with DCM, We enrolled a total of 2122 patients, excluding those who did not meet the requirements. A total of 913 patients were included in the analysis (611 males and 302 females) from October 2012 to May 2020, and data on demographic characteristics, blood biochemical markers, and cardiac ultrasound results were collected. Patients were strictly screened for DCM based on the diagnostic criteria. First, these patients were evaluated using propensity score matching (PSM). Next, unconditional logistic regression was used to assess HF risk. Furthermore, receiver operating characteristic (ROC) curve analysis was conducted to determine diagnostic efficiency, and a nomogram was developed to predict HF. Finally, the Kaplan\u2012Meier survival curve was plotted. Of the initial 2122 patients, the ejection fraction (EF) in males was worse. We included 913 patients after the final DCM diagnosis. The results showed that the levels of NT-proBNP, WBC, PLT, neutrophils, lymphocytes, eosinophils, and IL-6, C-reactive protein (CRP) and the neutrophil\/lymphocyte ratio (NLR), platelet\/lymphocyte ratio (PLR), and CRP\/lymphocyte ratio (CLR) were higher in males than in females (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001\u20130.009). The nomogram showed that factors such as sex, WBC, neutrophils, PLR, and CLR could predict the risk of worsening cardiac function in patients with DCM before and after PSM (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The ROC curve showed that CLR with an 85.6% area demonstrated higher diagnostic efficacy than the NLR (77.0%) and PLR (76.6%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Survival analysis showed a higher mortality risk in females with higher CLR levels (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001\u20130.009). However, high CLR levels indicated a higher mortality risk (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) compared to sex. Male EF is lower in DCM patients. CLR could predict the risk of declined cardiac function in patients with DCM. The mortality in females with higher CLR levels was highest; however, the exact mechanism should be investigated.<\/jats:p>","DOI":"10.1038\/s41598-023-46338-y","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T11:02:06Z","timestamp":1698922926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring the diagnostic and prognostic value of the C-reactive protein\/lymphocyte ratio for dilated cardiomyopathy based on a real-world study"],"prefix":"10.1038","volume":"13","author":[{"given":"Bin","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"46338_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"HP Schultheiss","year":"2019","unstructured":"Schultheiss, H. P. et al. Dilated cardiomyopathy. Nat Rev Dis Prim 5, 32 (2019).","journal-title":"Nat Rev Dis Prim"},{"issue":"47","key":"46338_CR2","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"C Lam","year":"2019","unstructured":"Lam, C. et al. Sex differences in heart failure. Eur Heart J 40(47), 3859\u20133868c (2019).","journal-title":"Eur Heart J"},{"key":"46338_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00395-021-00897-1","volume":"116","author":"M Rao","year":"2021","unstructured":"Rao, M. et al. Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level. Basic Res Cardiol 116, 55 (2021).","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"46338_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat Rev Immunol 16(10), 626\u2013638 (2016).","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"46338_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183874","volume":"12","author":"K InanlooRahatloo","year":"2017","unstructured":"InanlooRahatloo, K. et al. Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease. PLoS One 12(8), e0183874 (2017).","journal-title":"PLoS One"},{"issue":"4","key":"46338_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/10641963.2018.1510942","volume":"41","author":"B Srinivasagopalane","year":"2019","unstructured":"Srinivasagopalane, B., Andrew Rajarathinam, S. & Balasubramaiyan, T. Clinical pertinence of neutrophil-to-lymphocyte ratio among hypertensives with different grades and duration of hypertension\u2014An insight. Clin Exp Hypertens 41(4), 394\u2013399 (2019).","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"46338_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12872-020-01500-6","volume":"20","author":"J Larmann","year":"2020","unstructured":"Larmann, J. et al. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery. BMC Cardiovasc Disord 20(1), 230 (2020).","journal-title":"BMC Cardiovasc Disord"},{"key":"46338_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5217\/ir.2020.00146","volume":"20","author":"D Con","year":"2022","unstructured":"Con, D., Andrew, B., Nicolaides, S., van Langenberg, D. R. & Vasudevan, A. Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy. Intest Res 20, 101\u2013113 (2022).","journal-title":"Intest Res"},{"key":"46338_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5262","volume":"360","author":"X Sun","year":"2018","unstructured":"Sun, X., Tan, J., Tang, L., Guo, J. J. & Li, X. Real world evidence: Experience and lessons from China. BMJ 360, j5262 (2018).","journal-title":"BMJ"},{"issue":"3","key":"46338_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ejhf.16","volume":"16","author":"M Merlo","year":"2014","unstructured":"Merlo, M. et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: Changing mortality over the last 30 years. Eur J Heart Fail 16(3), 317\u2013324 (2014).","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"46338_CR11","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt, B. et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American heart association. Circulation 134(23), e579\u2013e646 (2016).","journal-title":"Circulation"},{"key":"46338_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","volume":"196","author":"N van Boven","year":"2018","unstructured":"van Boven, N. et al. Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study. Am Heart J. 196, 36\u201348 (2018).","journal-title":"Am Heart J."},{"issue":"1","key":"46338_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","volume":"116","author":"P Pellicori","year":"2020","unstructured":"Pellicori, P. et al. High-sensitivity C-reactive protein in chronic heart failure: Patient characteristics, phenotypes, and mode of death. Cardiovasc Res 116(1), 91\u2013100 (2020).","journal-title":"Cardiovasc Res"},{"issue":"13","key":"46338_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.122.059435","volume":"146","author":"A Yaku","year":"2022","unstructured":"Yaku, A. et al. Regnase-1 prevents pulmonary arterial hypertension through mRNA degradation of interleukin-6 and platelet-derived growth factor in alveolar macrophages. Circulation 146(13), 1006\u20131022 (2022).","journal-title":"Circulation"},{"issue":"8","key":"46338_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0002-9149(96)00063-X","volume":"79","author":"GA MacGowan","year":"1997","unstructured":"MacGowan, G. A., Mann, D. L., Kormos, R. L., Feldman, A. M. & Murali, S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 79(8), 1128\u20131131 (1997).","journal-title":"Am J Cardiol"},{"issue":"10","key":"46338_CR16","first-page":"1006","volume":"11","author":"I Ka\u017eukauskien\u0117","year":"2021","unstructured":"Ka\u017eukauskien\u0117, I. et al. Inflammation-related biomarkers are associated with heart failure severity and poor clinical outcomes in patients with non-ischemic dilated cardiomyopathy. Life (Basel) 11(10), 1006 (2021).","journal-title":"Life (Basel)"},{"issue":"7","key":"46338_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1253\/circj.70.857","volume":"70","author":"C Ishikawa","year":"2006","unstructured":"Ishikawa, C. et al. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 70(7), 857\u2013863 (2006).","journal-title":"Circ J"},{"issue":"50","key":"46338_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013386","volume":"97","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Cao, Y., Xin, L., Gao, N. & Liu, B. Association between rs1800629 polymorphism in tumor necrosis factor-\u03b1 gene and dilated cardiomyopathy susceptibility: Evidence from case-control studies. Medicine (Baltimore) 97(50), e13386 (2018).","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"46338_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/jcm10030504","volume":"10","author":"M Povar-Echeverr\u00eda","year":"2021","unstructured":"Povar-Echeverr\u00eda, M. et al. Interleukin-6 could be a potential prognostic factor in ambulatory elderly patients with stable heart failure: Results from a pilot study. J Clin Med 10(3), 504 (2021).","journal-title":"J Clin Med"},{"issue":"8","key":"46338_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ejhf.1482","volume":"21","author":"G Markousis-Mavrogenis","year":"2019","unstructured":"Markousis-Mavrogenis, G. et al. The clinical significance of interleukin-6 in heart failure: Results from the BIOSTAT-CHF study. Eur J Heart Fail 21(8), 965\u2013973 (2019).","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"46338_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.transproceed.2017.11.060","volume":"50","author":"JM Sobrino-M\u00e1rquez","year":"2018","unstructured":"Sobrino-M\u00e1rquez, J. M. et al. Prognostic Value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure. Transplant Proc 50(2), 650\u2013652 (2018).","journal-title":"Transplant Proc"},{"issue":"3","key":"46338_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","volume":"107","author":"S Uthamalingam","year":"2011","unstructured":"Uthamalingam, S. et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 107(3), 433\u2013438 (2011).","journal-title":"Am J Cardiol"},{"issue":"1","key":"46338_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/apc.APC_47_18","volume":"12","author":"F Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo, F., Silva, R., Oliveira, C. & Meira, Z. Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence. Ann Pediatr Cardiol 12(1), 18\u201324 (2019).","journal-title":"Ann Pediatr Cardiol"},{"issue":"4","key":"46338_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/14017431.2014.932922","volume":"48","author":"A Avci","year":"2014","unstructured":"Avci, A. et al. Neutrophil\/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Scand Cardiovasc J 48(4), 202\u2013208 (2014).","journal-title":"Scand Cardiovasc J"},{"issue":"10","key":"46338_CR25","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel, F. A. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol 92(10), 1733\u20131734 (2020).","journal-title":"J Med Virol"},{"issue":"2","key":"46338_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/SLA.0000000000003239","volume":"272","author":"Y Okugawa","year":"2020","unstructured":"Okugawa, Y. et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 272(2), 342\u2013351 (2020).","journal-title":"Ann Surg"},{"key":"46338_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/joim.13556","volume":"293","author":"D Harding","year":"2023","unstructured":"Harding, D. et al. Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy. J Intern Med 293, 23\u201347 (2023).","journal-title":"J Intern Med"},{"issue":"3","key":"46338_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","volume":"28","author":"A Lala","year":"2022","unstructured":"Lala, A. et al. Sex differences in heart failure. J Card Fail 28(3), 477\u2013498 (2022).","journal-title":"J Card Fail"},{"issue":"4","key":"46338_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/acr.21861","volume":"65","author":"F Aslam","year":"2013","unstructured":"Aslam, F., Bandeali, S. J., Khan, N. A. & Alam, M. Diastolic dysfunction in rheumatoid arthritis: A meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65(4), 534\u2013543 (2013).","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"46338_CR30","doi-asserted-by":"publisher","first-page":"1051652","DOI":"10.1155\/2022\/1051652","volume":"2022","author":"L Liang","year":"2022","unstructured":"Liang, L. et al. Expression profile of inflammation response genes and potential regulatory mechanisms in dilated cardiomyopathy. Oxid Med Cell Longev 2022, 1051652 (2022).","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"46338_CR31","doi-asserted-by":"publisher","first-page":"8513","DOI":"10.1038\/s41598-022-12249-7","volume":"12","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Wang, H. Y., Jian, W., Yang, Z. J. & Gui, C. Development and validation of a nomogram to predict the risk of death within 1 year in patients with non-ischemic dilated cardiomyopathy: a retrospective cohort study. Sci Rep 12(1), 8513 (2022).","journal-title":"Sci Rep"},{"key":"46338_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46, 399\u2013424 (2011).","journal-title":"Multivar Behav Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46338-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T19:03:20Z","timestamp":1698951800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46338-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46338"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46338-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18889"}}